COVID-19 Update | October 16, 2020

COVID-19 News

COVID-19 Update | October 16, 2020

October 16, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of October 16, 2020. Notable advancements include:

  • Sanofi and Translate Bio are moving into phase 2 trials of their COVID-19 mRNA vaccine after positive data results.
  • Pfizer received approval from regulators to expand a trial to include children as young as 12, becoming the first major drugmaker to open a COVID-19 vaccine trial to kids.
  • Takeda is moving into stage 3 trials of its plasma therapy drug and aims to enroll 500 patients.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].